1. Falup-Pecurariu OG, Diez-Domingo J, Esposito S, Finn A, Rodrigues F, Spoulou V, et al. Clinical and laboratory features of children with community-acquired pneumonia are associated with distinct radiographic presentations. European journal of pediatrics. 2018.

2. Guillard-Maure C, Elango V, Black S, Perez-Vilar S, Castro JL, Bravo-Alcantara P, et al. Operational lessons learned in conducting a multi-country collaboration for vaccine safety signal verification and hypothesis testing: The global vaccine safety multi country collaboration initiative. Vaccine. 2018;36(3):355-62.

3. Mira-Iglesias A, Xavier Lopez-Labrador F, Guglieri-Lopez B, Tortajada-Girbes M, Baselga-Moreno V, Cano L, et al. Influenza vaccine effectiveness in preventing hospitalisation of individuals 60 years of age and over with laboratory-confirmed influenza, Valencia Region, Spain, influenza season 2016/17. Eurosurveillance. 2018;23(8):7-15.

4. Munoz-Quiles C, Lopez-Lacort M, Diez-Domingo J. Risk and impact of herpes zoster among COPD patients: a population-based study, 2009-2014. Bmc Infectious Diseases. 2018;18.

5. Munoz-Quiles C, Lopez-Lacort M, Orrico-Sanchez A, Diez-Domingo J. Impact of postherpetic neuralgia: A six year population-based analysis on people aged 50 years or older. The Journal of infection. 2018.

6. Munoz-Quiles C, Lopez-Lacort M, Orrico-Sanchez A, Diez-Domingo J. Letter to the editor regarding "The role of age-sex interaction in the development of post-herpetic neuralgia". Human Vaccines & Immunotherapeutics. 2018;14(4):906-8.

7. Orrico-Sanchez A, Lopez-Lacort M, Munoz-Quiles C, Diez-Domingo J. Lack of impact of rotavirus vaccines on seizure-related hospitalizations in children under 5years old in Spain. Human vaccines & immunotherapeutics. 2018:1-5.

8. Perez-Vilar S, Weibel D, Sturkenboom M, Black S, Maure C, Castro JL, et al. Enhancing global vaccine pharmacovigilance: Proof-of-concept study on aseptic meningitis and immune thrombocytopenic purpura following measles-mumps containing vaccination. Vaccine. 2018;36(3):347-54.

9. Puig-Barberà J, Mira-Iglesias A, Tortajada-Girbés M, López-Labrador FX, Librero-López J, Díez-Domingo J, Carballido-Fernández M, Carratalá-Munuera C, Correcher-Medina P, Gil-Guillén V, Limón-Ramírez R, Mollar-Maseres J, Otero-Reigada MC, Schwarz-Chavarri G. Waning protection of influenza vaccination during four influenza seasons, 2011/2012 to 2014/2015. Vaccine. 2017 Oct 13;35(43):5799-5807. doi: 10.1016/j.vaccine.2017.09.035.

10. Tom De Smedt, Elizabeth Merrall, Denis Macina, Silvia Perez-Vilar, Nick Andrews, Kaatje Bollaerts. Bias due to differential and non-differential disease- and exposure misclassification in studies of vaccine effectiveness. PLoS One. 2018 Jun 15;13(6):e0199180. doi: 10.1371/journal.pone.0199180. eCollection 2018.

11. Martinón-Torres F, Diez-Domingo J, Feroldi E, Jordanov E, B'Chir S, Da Costa X. Evaluation of a Hexavalent-Pentavalent-Hexavalent Infant Primary Vaccination Series Followed by a Pentavalent Booster Vaccine in Healthy Infants and Toddlers. Pediatr Infect Dis J. 2018 Nov 7. doi: 10.1097/INF.0000000000002231

12. Pepin S, Dupuy M, Borja-Tabora CFC, Montellano M, Bravo L, Santos J, de Castro JA, Rivera-Medina DM, Cutland C, Ariza M, Diez-Domingo J, Gonzalez CD, Martinón-Torres F, Papadopoulou-Alataki E, Theodoriadou M, Kazek-Duret MP, Gurunathan S, De Bruijn I; GQM05 Study Group. Efficacy, immunogenicity, and safety of a quadrivalent inactivated influenza vaccines in children aged 6-35 month: A multi season randomised placebo-controlled trial in the Northern and Southern Hemispheres. Vaccine. 2018 Dec 14. pii: S0264-410X(18)31637-2. doi: 10.1016/j.vaccine.2018.11.074.

13. Ortiz de Lejarazu R, Díez Domingo J, Gil de Miguel A, Martinón Torres F, Guzmán Quilo C, Guillén JM, Piedrafita B, Redondo Marguello E. Description of Influenza B in seasonal epidemics in Spain. Rev Esp Quimioter. 2018 Dec;31(6):511-519. Epub 2018 Nov 5.